Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pembrolizumab versus chemotherapy in Chinese participants with stage IV colorectal cancer (MK-3475-C66) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colorectal Neoplasms | Phase 3 | Status: RECRUITING